Xin Hu

4.7k total citations
96 papers, 2.5k citations indexed

About

Xin Hu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xin Hu has authored 96 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 40 papers in Molecular Biology and 36 papers in Cancer Research. Recurrent topics in Xin Hu's work include Cancer Genomics and Diagnostics (13 papers), Breast Cancer Treatment Studies (13 papers) and RNA modifications and cancer (11 papers). Xin Hu is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Breast Cancer Treatment Studies (13 papers) and RNA modifications and cancer (11 papers). Xin Hu collaborates with scholars based in China, United States and South Korea. Xin Hu's co-authors include Zhi‐Ming Shao, Yue Gong, Peng Ji, Yi‐Rong Liu, Zhi-Ming Shao, Jianrong Lu, Tianming Lin, Brian K. Law, Yi‐Zhou Jiang and Xiao‐En Xu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xin Hu

93 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Hu China 27 1.3k 967 822 406 377 96 2.5k
Marcello Maugeri‐Saccà Italy 25 1.5k 1.1× 1.0k 1.0× 800 1.0× 350 0.9× 211 0.6× 66 2.6k
Germana Castelli Italy 29 1.6k 1.3× 798 0.8× 950 1.2× 478 1.2× 400 1.1× 97 3.1k
Arja Jukkola‐Vuorinen Finland 25 898 0.7× 1.0k 1.0× 800 1.0× 341 0.8× 369 1.0× 51 2.2k
Daniele Fanale Italy 29 1.2k 1.0× 979 1.0× 922 1.1× 437 1.1× 274 0.7× 84 2.5k
Rafał Matkowski Poland 28 865 0.7× 1.2k 1.3× 696 0.8× 316 0.8× 363 1.0× 183 2.3k
Yan Mao China 23 839 0.6× 1.0k 1.0× 748 0.9× 338 0.8× 421 1.1× 64 2.1k
Jianjun He China 27 940 0.7× 837 0.9× 846 1.0× 433 1.1× 386 1.0× 86 2.2k
Yoshihisa Tokumaru Japan 28 1.1k 0.8× 1.1k 1.1× 859 1.0× 714 1.8× 507 1.3× 91 2.2k
Geng Zhang China 18 1.5k 1.2× 764 0.8× 899 1.1× 283 0.7× 411 1.1× 76 2.5k
Nils Brünner Denmark 29 1.2k 0.9× 1.0k 1.1× 972 1.2× 322 0.8× 226 0.6× 96 2.4k

Countries citing papers authored by Xin Hu

Since Specialization
Citations

This map shows the geographic impact of Xin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Hu more than expected).

Fields of papers citing papers by Xin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Hu. The network helps show where Xin Hu may publish in the future.

Co-authorship network of co-authors of Xin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Hu. A scholar is included among the top collaborators of Xin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Hu. Xin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hongquan, Yifei He, Zhen Liu, et al.. (2025). CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription. Nature Communications. 16(1). 7409–7409. 1 indexed citations
2.
Lin, Cai‐Jin, Xi Jin, Ding Ma, et al.. (2024). Genetic interactions reveal distinct biological and therapeutic implications in breast cancer. Cancer Cell. 42(4). 701–719.e12. 14 indexed citations
3.
Shao, Zhi‐Ming, et al.. (2024). Multiomics and single‐cell sequencings reveal the specific biological characteristics of low Ki‐67 triple‐negative breast cancer. SHILAP Revista de lepidopterología. 3(5). e146–e146. 1 indexed citations
4.
Hu, Xin, et al.. (2024). Fuzzy reliability evaluation and machine learning-based fault prediction of wind turbines. Journal of Industrial Information Integration. 40. 100606–100606. 14 indexed citations
5.
Cai, Qian, Zhen Wang, Jianming Li, et al.. (2024). Relationship between postablation fever and prognosis in initial hepatocellular carcinoma: a 15-year multicenter, retrospective cohort study. International Journal of Surgery. 111(1). 962–971.
6.
Lü, Jinhui, Qian Zhao, Danni Li, et al.. (2023). Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling. Journal of Experimental & Clinical Cancer Research. 42(1). 93–93. 13 indexed citations
7.
Lu, Xun‐Xi, et al.. (2023). An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression. Cancer Research. 83(12). 2000–2015. 11 indexed citations
8.
Yu, Tian‐Jian, Yingying Liu, Xiaoguang Li, et al.. (2021). PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer. Cancer Research. 81(21). 5491–5505. 32 indexed citations
9.
Wei, Jinli, Siyu Wu, Yun‐Song Yang, et al.. (2021). GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 9(7). e002383–e002383. 41 indexed citations
10.
Wu, Siyu, Yi Xiao, Jinli Wei, et al.. (2021). MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 9(7). e002528–e002528. 62 indexed citations
11.
Guo, Linwei, Xiaoguang Li, Xun‐Xi Lu, et al.. (2021). Large‐scale genomic sequencing reveals adaptive opportunity of targeting mutated‐PI3Kα in early and advanced HER2‐positive breast cancer. SHILAP Revista de lepidopterología. 11(11). e589–e589. 10 indexed citations
12.
Li, Xiaoguang, et al.. (2020). Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China. BMC Cancer. 20(1). 244–244. 11 indexed citations
13.
14.
15.
Jiang, Yi-Zhou, Yi‐Rong Liu, Xiao‐En Xu, et al.. (2016). Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value. Cancer Research. 76(8). 2105–2114. 157 indexed citations
16.
Cao, Zhi-Gang, Xia Chen, Li Chen, et al.. (2015). Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer. Cancer Research. 75(7). 1504–1515. 69 indexed citations
17.
Hu, Xin, et al.. (2014). Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer. Annals of Surgical Oncology. 21(S4). 648–656. 10 indexed citations
18.
19.
Hu, Xin, et al.. (2011). NBA1/MERIT40 and BRE Interaction Is Required for the Integrity of Two Distinct Deubiquitinating Enzyme BRCC36-containing Complexes. Journal of Biological Chemistry. 286(13). 11734–11745. 57 indexed citations
20.
Huang, Jian, Yun Lin, Lihua Li, et al.. (2008). ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis. Molecular Carcinogenesis. 48(2). 130–140. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcello Maugeri‐Saccà Breakdown of academic impact, for papers by Germana Castelli Breakdown of academic impact, for papers by Arja Jukkola‐Vuorinen Breakdown of academic impact, for papers by Daniele Fanale Breakdown of academic impact, for papers by Rafał Matkowski Breakdown of academic impact, for papers by Yan Mao Breakdown of academic impact, for papers by Jianjun He Breakdown of academic impact, for papers by Yoshihisa Tokumaru Breakdown of academic impact, for papers by Geng Zhang Breakdown of academic impact, for papers by Nils Brünner
Rankless by CCL
2026